The unexpected drivers of waste in clinical trial manufacturing

The period from preclinical through commercialization comes with a lot of unpredictability and challenges for all organizations. Although buffers are needed to meet the developmental needs and patient supply requirements, a lot of waste in clinical manufacturing can be pro-actively avoided by using a more global approach, better controlling your risk at every level, and making data-driven decisions.

In this webinar, we will focus on which decisions can cause overlooked drug waste and how biotechs and pharma organizations can make the most effective use of their manufacturing capabilities and budgets.

Join us to learn how:

• Localized decisions can have very detrimental impacts on the global efficiency of your supply chain;
• Globalizing and controlling buffers in an end-to-end way can help minimize waste;
• Decisions and processes that are often seen as fixed and unchangeable can be challenged and consequently yield considerable benefits;
• N-SIDE has been able to drastically increase usage rates, therefore accelerating time to market and reducing clinical budgets through optimization, facts and collaboration.